Stenting in Palliation of Unresectable Esophageal Cancer
Open Access
- 26 June 2018
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 42 (12) , 3988-3996
Abstract
Background: The aim of this study was to analyze the safety and effectiveness of stenting using partially covered self‐expandable stents in palliation of dysphagia in patients with unresectable esophageal cancer.Methods: Retrospective analysis of hospital records of all patients who underwent esophageal stenting in the period 2008–2015 was performed. The study included patients with unresectable esophageal and esophagogastric cancer.Results: There were 442 patients included. Mean age was 56 years (range 28–89), and 379 were males. In 40 (9.0%) patients, stenting was performed in the cervical, in 150 (39.3%)—in the middle thoracic, in 141 (31.9%)—in lower thoracic esophagus and in 111 (25.1%)—in the esophagogastric junction. Stenting resulted in significant alleviation of dysphagia grade (3.0 vs. 1.0, p = 0.00001). During the follow‐up, 55 (12.4%) patients experienced recurrent dysphagia due to tumor or granulation tissue overgrowth, and in 18 (4.1%) patients, migration of the stent occurred, for which an independent risk factor was adjuvant chemo‐ and/or radiation therapy (p = 0.001). Minor complications included chest pain (54.5%), delayed complete stent expansion (12.0%), feeling of a foreign body (25.3%), hiccup (1.6%), gastroesophageal reflux (45.6%) and post‐discharge pneumonia (2.5%). A feeling of a foreign body in the esophagus was significantly more common after stenting of the cervical esophagus (p = 0.0001), and hiccup was more common after stenting of the esophagogastric junction (p = 0.02). Major complications included bleeding (1.3%), respiratory insufficiency (0.7%), esophageal perforation (0.9%) and irregular heartburn (2.3%). Overall procedure‐related mortality was 0.4%. The median survival time was 117.8 days (range 2–732).Conclusions: Stenting is an effective procedure in relieving dysphagia in patients with unresectable malignant esophageal stenosis and is associated with low rate of postoperative and long‐term complications.Keywords
This publication has 40 references indexed in Scilit:
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- The Use of Self-Expanding Stents in Esophageal and Gastroesophageal Junction Cancer Palliation: A Meta-Analysis and Meta-Regression Analysis of OutcomesDigestive Diseases and Sciences, 2010
- Self-expandable Metallic Stents for Palliative Treatment of Digestive CancerJournal of Clinical Gastroenterology, 2008
- Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric studyEuropean Journal of Gastroenterology & Hepatology, 2007
- Development of severe complications caused by stent placement followed by definitive radiation therapy for T4 esophageal cancerInternational Journal of Clinical Oncology, 2003
- Bronchoscopic management of central airway obstructionThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Quality of life measurement in patients with oesophageal cancer.Gut, 1995
- Self-expanding Mesh Stent for Esophageal Cancer StenosisEndoscopy, 1990
- Endoscopic Tube Implantation for the Palliation of Malignant Esophageal StenosisEndoscopy, 1990
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948